Cboe CA - Delayed Quote CAD

The Cannabist Company Holdings Inc. (CBST.NE)

Compare
0.1100 +0.0200 (+22.22%)
At close: January 3 at 3:59:59 PM EST
Loading Chart for CBST.NE
DELL
  • Previous Close 0.0900
  • Open 0.1000
  • Bid 0.1100 x --
  • Ask 0.1150 x --
  • Day's Range 0.0950 - 0.1200
  • 52 Week Range 0.0675 - 0.8200
  • Volume 773,109
  • Avg. Volume 646,019
  • Market Cap (intraday) 51.148M
  • Beta (5Y Monthly) 1.46
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4300
  • Earnings Date Mar 11, 2025 - Mar 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.80

The Cannabist Company Holdings Inc. engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. The company provides flower, concentrates, edibles, and/or accesories, and medicinal cannabinoid capsules and tablets, as well as confections, chocolate, drink mixes, condiments, kief, shatter, and wax/crumble, under the Seed & Strain, Classix, and Triple Seven brand names. It offers management services to licensed entities. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The Cannabist Company Holdings Inc. was founded in 2012 and is headquartered in New York, New York.

www.cannabistcompany.com

2,191

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CBST.NE

View More

Performance Overview: CBST.NE

Trailing total returns as of 1/6/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

CBST.NE
46.67%
MSCI WORLD
0.55%

1-Year Return

CBST.NE
86.25%
MSCI WORLD
19.83%

3-Year Return

CBST.NE
97.04%
MSCI WORLD
16.75%

5-Year Return

CBST.NE
96.76%
MSCI WORLD
0.00%

Compare To: CBST.NE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CBST.NE

View More

Valuation Measures

As of 1/3/2025
  • Market Cap

    51.99M

  • Enterprise Value

    695.44M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.07

  • Price/Book (mrq)

    1.45

  • Enterprise Value/Revenue

    0.98

  • Enterprise Value/EBITDA

    178.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -25.27%

  • Return on Assets (ttm)

    -0.02%

  • Return on Equity (ttm)

    -140.14%

  • Revenue (ttm)

    490.95M

  • Net Income Avi to Common (ttm)

    -124.06M

  • Diluted EPS (ttm)

    -0.4300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    32.68M

  • Total Debt/Equity (mrq)

    1,992.06%

  • Levered Free Cash Flow (ttm)

    28.88M

Research Analysis: CBST.NE

View More

People Also Watch